Fig. 1
From: CRISPR–Cas9 applications in T cells and adoptive T cell therapies
CRISPR–Cas9 editing of the transcription factor Foxp3, along with the modulation of metabolism regulators and the engineering of TCR and CAR in Treg cells, can enable these cells to play distinct roles in autoimmune diseases and tumor environments